行銷硏究 : Marketing research

This article presents an introduction to the Health Belief Model (HBM). The HBM states that the perception of a personal health behavior threat is influenced by at least three factors: general health values, interest and concern about health; specific beliefs about vulnerability to a particular health threat; and beliefs about the consequences of the health problem. Once an individual perceives a threat to his health and is simultaneously cued to action, if his perceived benefits outweighs his perceived costs, then the individual is most likely to undertake the recommended preventive health action. Key words: health promotion, health belief model, perceived susceptibility, perceived severity, perceived benefits, perceived barriers, cues to action, self-efficacy. Content available only in Romanian.

Health Belief Model

Nutrient requirements of dairy cattle , Nutrient requirements of dairy cattle , مرکز فناوری اطلاعات و اطلاع رسانی کشاورزی

Nutrient requirements of dairy cattle

Neospora caninum is a protozoan parasite of animals. Until 1988, it was misidentified as Toxoplasma gondii. Since its first recognition in dogs in 1984 and the description of the new genus and species Neospora caninum in 1988, neosporosis has emerged as a serious disease of cattle and dogs worldwide. Abortions and neonatal mortality are a major problem in livestock operations, and neosporosis is a major cause of abortion in cattle. Although antibodies to N. caninum have been reported, the parasite has not been detected in human tissues. Thus, the zoonotic potential is uncertain. This review is focused mainly on the epidemiology and control of neosporosis in cattle, but worldwide seroprevalences of N. caninum in animals and humans are tabulated. The role of wildlife in the life cycle of N. caninum and strategies for the control of neosporosis in cattle are discussed.

/pdf/epidemiology-and-control-of-neosporosis-and-neospora-caninum-3wbu38pknw.pdf

Epidemiology and Control of Neosporosis and Neospora caninum

This book opens a fresh chapter in the debate on local enterprise clusters and their strategies for upgrading in the global economy. The authors employ a novel conceptual framework in their research on industrial clusters in Europe, Latin America and Asia and provide new perspectives and insights for researchers and policymakers alike.

Governance in global value chains

Several studies have been published since 1990 on the economics of mastitis and mastitis management However, hardly any of these studies has discussed the consistency of results with other studies In the present paper, the economic factors associated with mastitis are explained, providing a framework for economic analysis As a second step calculations of the costs of mastitis and the costs in relation to the benefits of mastitis management published since 1990 in peer-reviewed journals are extensively reviewed and analysed The result shows a large variation in the calculated costs and benefits of mastitis and mastitis management between the different studies Moreover, it is clear that important factors were ignored in some of the studies The framework provided in this paper can provide a basis for analysis for future studies on the economics of mastitis and mastitis management

Economic effects of bovine mastitis and mastitis management: a review.

Good udder health is not only important for the dairy farmer but, because of increasing interest of consumers in the way dairy products are produced, also for the dairy production chain as a whole. An important role of veterinarians is in advising on production diseases such as mastitis. A large part of this advice is given around the planning of management to maintain or improve the udder health status of a farm. Mastitis is a costly disease, due to losses (a reduction of output due to mastitis) and expenditure (additional inputs to reduce the level of mastitis). Worldwide, published estimates of the economic losses of clinical mastitis range from €61 to €97 per cow on a farm, with large differences between farms, e.g. in The Netherlands, losses due to clinical and subclinical mastitis varied between €17 and €198 per cow per year. Moreover, farmers tended to underestimate these costs. This indicates that for a large proportion of farms there are many avoidable losses. In order to provide good support to farmers' decision-making, it is important to describe the mastitis setting not only in terms of disease, e.g. incidence of clinical mastitis, but also in monetary terms; and to make good decisions, it is necessary to provide the dairy farmer with information on the additional expenditure and reduced losses associated with alternative decisions. Six out of 18 preventive measures were shown to have a positive nett benefit, viz blanket use of dry-cow therapy, keeping cows standing after milking, back-flushing of the milk cluster after milking a cow with clinical mastitis, application of a treatment protocol, washing dirty udders, and the use of milkers' gloves. For those measures that included a large amount of routine labour or investment, the reduced losses did not outweigh the additional expenditure. The advisor cannot expect that measures that are cost-effective are always implemented. Reasons for this are the objectives of the dairy farmer can be other than maximisation of profit, resources to improve the mastitis situation compete with other fields of management, risk involved with the decision, economic behaviour of the dairy farmer, and valuation of the cost factors by the dairy farmer. For all decision-makers this means that, although financial incentives do have an effect on the management of mastitis, it is not always sufficient to show the economic benefits of improved management to induce an improvement of management of mastitis.

Economic aspects of mastitis: New developments

Invited review: sensors to support health management on dairy farms.

A model to calculate the economic losses of mastitis on an average Dutch dairy farm was developed and used as base for a tool for farmers and advisors to calculate farm-specific economic losses of mastitis. The economic losses of a clinical case in a default situation were calculated as euro210, varying from euro164 to euro235 depending on the month of lactation. The total economic losses of mastitis (subclinical and clinical) per cow present in a default situation varied between euro65 and euro182/cow per year depending on the bulk tank somatic cell count. The tool was used to measure perception of the total economic losses of mastitis on the farm and the farmers' assessment of the cost factors of mastitis on 78 dairy farms, of which 64 were used for further analyses. Most farmers (72%) expected their economic losses to be lower than those revealed by our calculation made with their farm information. Underestimating the economic losses of mastitis can be regarded as a general problem in the dairy sector. The average economic losses assessed by the farmers were euro78/cow per year, but a large variation was given, euro17-198/cow per year. Although the average assessment of the farmers of the different cost factors is close to the default value, there is much variation. To improve the adoption rate of advice and lower the incidence of mastitis, it is important to show the farmers the economic losses of mastitis on their farm. The tool described in this paper can play a role in that process.

https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S0022029907002932

Henk Hogeveen

Papers

Economic effects of bovine mastitis and mastitis management: a review.

Economic aspects of mastitis: New developments

Invited review: sensors to support health management on dairy farms.

Costs of mastitis: facts and perception.

Assessing economic consequences of foot disorders in dairy cattle using a dynamic stochastic simulation model